AstraZeneca Names New CEO, Faces More Competition

Aug. 28 (Bloomberg) -- Bloomberg's Erik Schatzker reports that AstraZeneca named Pascal Soriot as chief executive officer as the company faces increased generic competition. He speaks on Bloomberg Television's "Market Makers." (Source: Bloomberg)

What Are Today's Takeaways from Trump's Actions?
17:48 - Bloomberg's Margaret Talev reports on President Donald Trump’s conversation with Canadian President Justin Trudeau and the memoranda on the Keystone XL and Dakota Access pipelines. She speaks on "What'd You Miss?" (Source: Bloomberg)
  • Here's Why the Fed Could Opt to Be Dovish
  • Is It the End of the Bond Bull Market?
  • Options Insight: How to Play Valeant